Health Catalyst (HCAT) Receivables - Other (2018 - 2026)

Health Catalyst has reported Receivables - Other for 9 years, with the latest figure at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 15.58% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (down 15.58% YoY), and the FY2025 full-year result was $10.1 million, down 14.41% from the prior year.
• Receivables - Other for Q1 2026 stood at $6.5 million, down from $10.1 million in the prior quarter.
• The five-year high for Receivables - Other was $11.8 million in Q4 2024, with the low at $500000.0 in Q2 2022.
• Historically, Receivables - Other has averaged $5.0 million across 5 years, with a median of $4.7 million in 2023.
• Annual changes were most pronounced in 2022 — Receivables - Other slumped 58.33% — and 2023, when it jumped 422.22%.
• Health Catalyst's Receivables - Other stood at $900000.0 in 2022, then jumped by 422.22% to $4.7 million in 2023, then surged by 151.06% to $11.8 million in 2024, then declined by 14.41% to $10.1 million in 2025, then sank by 35.64% to $6.5 million in 2026.
• The last three Receivables - Other figures came in at $6.5 million (Q1 2026), $10.1 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.